BioPharma Nexus is a dynamic conference for top-notch Decision Makers and senior R&D professionals covering optimization and preclinical challenges of small molecule drug candidates. It highlights advances in current and emerging “hot” Targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.

We encourage networking to present your concerns in front of other drug hunters. Doing this helps you gather more knowledge and opens the doors to exploring future project ideas,Continuing to unite the most forward-thinking researchers from the biopharmaceutical industry, our unrivaled program will uncover but not limited to drug delivery, pharmacology, organic synthesis, structural biology, and medicinal chemistry.

BioPharma Nexus connects you with enthusiastic drug discovery leaders to grow your network and expertise simultaneously . As an attendee or sponsor, you can showcase in front of Decision Makers and network at the exhibition, and gain strategic insights into solutions for increasing the success of drug discovery and development.

[wgl_double_headings align=”center” title_color=”#232323″ subtitle_color=”#ff2d68″ bgtitle_size=”40px” bgtitle_weight=”600″ bgtitle_color=”#d5d5d5″ bgtitle=”Our Past Speakers” bg_responsive_font=”true” bg_font_size_desctop=”60″ bg_font_size_tablet=”60″ bg_font_size_mobile=”60″ custom_bgtitle_color=”true”]
[wgl_carousel slide_to_show=”4″ resp_medium_slides=”4″ resp_tablets_slides=”3″ resp_mobile_slides=”2″ infinite=”true” custom_resp=”true”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4020″ ib_title=”Caterina Musetti” ib_subtitle=”Principal Scientist” ib_content=”Bristol Myers Squibb” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4021″ ib_title=”Gunaretnam (Guna) Rajagopal” ib_subtitle=”Vice president” ib_content=”The Janssen Pharmaceutical Companies of Johnson & Johnson” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4022″ ib_title=”Hsueh-Yuan (Luke) Chang” ib_subtitle=”Senior Scientist” ib_content=”Boehringer Ingelheim” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4023″ ib_title=”Mike Hicks, Ph.D.” ib_subtitle=”Associate Principal Scientist” ib_content=”Merck” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4024″ ib_title=”Maria Lorenzo” ib_subtitle=”Principal Scientific Researcher” ib_content=”Genentech” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4025″ ib_title=”Regis Doyonnas” ib_subtitle=”Associate Research Fellow” ib_content=”PFIZER” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4026″ ib_title=”Eric Halioua” ib_subtitle=”President & Chief Executive Officer” ib_content=”PDC*line Pharma” extra_class=”present_icon”][wgl_info_box ib_type=”full_size” ib_align=”center” icon_type=”image” thumbnail=”4027″ ib_title=”Bradley Morgan” ib_subtitle=”Senior Vice President” ib_content=”Cytokinetics” extra_class=”present_icon”][/wgl_carousel]
[wgl_double_headings align=”center” title_color=”#232323″ subtitle_color=”#ff2d68″ bgtitle_size=”40px” bgtitle_weight=”600″ bgtitle_color=”#d5d5d5″ bgtitle=”Our Partners” bg_responsive_font=”true” bg_font_size_desctop=”60″ bg_font_size_tablet=”60″ bg_font_size_mobile=”60″ custom_bgtitle_color=”true”]
X